Home › Compare › PARDP vs ABBV

PARDP vs ABBV: Dividend Comparison 2026

PARDP yields 7312500.00% · ABBV yields 3.67%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PARDP wins by $2.0819801999960142e+45M in total portfolio value
10 years
PARDP
PARDP
● Live price
7312500.00%
Share price
$0.00
Annual div
$7.31
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.0819801999960142e+45M
Annual income
$2,081,924,193,705,369,300,000,000,000,000,000,000,000,000,000,000,000.00
Full PARDP calculator →
ABBV
AbbVie Inc.
● Live price
3.67%
Share price
$168.90
Annual div
$6.20
5Y div CAGR
8.9%
Payout ratio
58%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.9K
Annual income
$1,154.43
Full ABBV calculator →

Portfolio growth — PARDP vs ABBV

📍 PARDP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPARDPABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PARDP + ABBV cover 4 of 12 months — good coverage

Jan
ABBV
Feb
—
Mar
—
Apr
ABBV
May
—
Jun
—
Jul
ABBV
Aug
—
Sep
—
Oct
ABBV
Nov
—
Dec
—
PARDP pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PARDP
Annual income on $10K today (after 15% tax)
$621,562,500.00/yr
After 10yr DRIP, annual income (after tax)
$1,769,635,564,649,563,700,000,000,000,000,000,000,000,000,000,000,000.00/yr
ABBV
Annual income on $10K today (after 15% tax)
$312.02/yr
After 10yr DRIP, annual income (after tax)
$981.27/yr
At 15% tax rate, PARDP beats the other by $1,769,635,564,649,563,700,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PARDP + ABBV for your $10,000?

PARDP: 50%ABBV: 50%
100% ABBV50/50100% PARDP
Portfolio after 10yr
$1.0409900999980071e+45M
Annual income
$1,040,962,096,852,684,600,000,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
100.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

PARDP
No analyst data
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+51.7% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PARDP buys
0
ABBV buys
0
No recent congressional trades found for PARDP or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPARDPABBV
Forward yield7312500.00% ✓3.67%
Annual dividend / share$7.31 ✓$6.20
Payout ratio50% ✓58%
1-year div growth0%4.7% ✓
5-year div CAGR0%8.9% ✓
Portfolio after 10y$2.0819801999960142e+45M$39.9K ✓
Annual income after 10y$2,081,924,193,705,369,300,000,000,000,000,000,000,000,000,000,000,000.00 ✓$1,154.43
Total dividends collected$2.0819765359469847e+45M$7.2K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PARDP vs ABBV ($10,000, DRIP)

YearPARDP PortfolioPARDP Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$731,260,700$731,250,000.00$11,520$399.75+$731.25M → PARDP
2$49,975,958,792,407$49,975,176,343,457.95$13,261$450.98+$49975958.78M → PARDP
3$3,192,028,307,619,219,500$3,191,974,833,343,311,400.00$15,255$508.41+$3192028307619.20M → PARDP
4$190,541,274,137,009,730,000,000$190,537,858,666,720,580,000,000.00$17,536$572.74+$190541274137009728.00M → PARDP
5$10,629,875,136,149,249,000,000,000,000$10,629,671,256,985,922,000,000,000,000.00$20,145$644.78+$1.0629875136149248e+22M → PARDP
6$554,222,389,729,048,400,000,000,000,000,000$554,211,015,762,652,700,000,000,000,000,000.00$23,126$725.38+$5.542223897290484e+26M → PARDP
7$27,005,785,655,664,404,000,000,000,000,000,000,000$27,005,192,637,707,395,000,000,000,000,000,000,000.00$26,532$815.52+$2.7005785655664403e+31M → PARDP
8$1,229,833,888,337,717,000,000,000,000,000,000,000,000,000$1,229,804,992,147,065,300,000,000,000,000,000,000,000,000.00$30,420$916.26+$1.2298338883377171e+36M → PARDP
9$52,342,327,705,682,610,000,000,000,000,000,000,000,000,000,000$52,341,011,783,422,090,000,000,000,000,000,000,000,000,000,000.00$34,855$1,028.80+$5.234232770568261e+40M → PARDP
10$2,081,980,199,996,014,300,000,000,000,000,000,000,000,000,000,000,000$2,081,924,193,705,369,300,000,000,000,000,000,000,000,000,000,000,000.00$39,914$1,154.43+$2.0819801999960142e+45M → PARDP

PARDP vs ABBV: Complete Analysis 2026

PARDP — Stock

PARDP is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in PARDP shares.

Full PARDP Calculator →

ABBV — Healthcare

AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.

Full ABBV Calculator →
📬

Get this PARDP vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PARDP vs SCHDPARDP vs JEPIPARDP vs OPARDP vs KOPARDP vs MAINPARDP vs JNJPARDP vs MRKPARDP vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.